Exciting new work from our lab!

Trying to write a grant but can’t stop watching our new pet, Mango. Bearded dragons are so cool.

The Florey is home to world renowned researchers advancing brain science and, with it, our collective quality of life.

We are thrilled to share with you this insight into our work, our purpose, and a new identity for our organisation.

Find out more: florey.edu.au 🧠

As a professor, pursue the careers of your PhD students and postdocs instead of pursuing your own.

I know it may sound strange and even provocative. But in fact it is how it’s supposed to be.

Unfortunately, a personal gain is the biggest motivation for many professors. More…

Elsevier revenue at 2.9 billion pounds, profit margin nearing 40% - the #OpenAccess model is an obscene fraud that wastes charity and public money. Finally some action by scientists though -

theguardian.com/science/2023/m…

It was an absolute pleasure to write a perspective on the amazing work from the lab of William McEwan published in Science that will hopefully lead to the development of better tau antibody therapies for the treatment of AD
science.org/doi/10.1126/sc…

science.org/doi/10.1126/sc…

This week in Science Magazine: Aamir Mukadam, William McEwan, &al. treat mouse models of #tau pathology w/ α-tau #antibodies by engaging cytosolic Ab receptor #TRIM21 !

bit.ly/Sci_abn1366

w/ Perspective by Rebecca Nisbet:

bit.ly/Sci_adg9800

#neurodegeneration #immunotherapy

Do anti-amyloid drugs protect the Alzheimer's brain? Francesca Alves Pav Kalinowski & I performed a meta-analysis of all clinical trials (8k-10k subjects) and showed that anti-amyloid drugs constantly accelerate brain atrophy, but the area of the brain affected depends on drug class

📣 We are looking for an RA to join our growing team at the Florey. Help us find a cure for dementia! Details in link floreyinstitute.applynow.net.au/jobs/FLOREY134

Glad to see our work on tau and abeta derived from AD brains (tangles/PHF/globular aggregates) is finally published in JNC #AD #Proteomics #Massspec

Academic writing resources developed by Harvard, Purdue, and the University of York (UK) — all free:

A meta-thread 🧵

Time to put down the tools! Another Honours year University of Melbourne coming to an end! Congratulations Alayna Carmina Caruso on a fantastic year in the lab. Good luck with the thesis writing and see you back here for a PhD!

Be the HA-tag
twitter.com/STFU_anajai2/s…

A professor once told me to, when editing, re-read your work separately for every editing 'theme'. Compartmentalising editing should make it more productive, rather than endlessly reviewing & finding different issues every time. Here's themes I cover when editing:

1/2 PhD Voice - Independently Run

Happy #nationalscienceweek ! To celebrate we have been doing exothermic and endothermic reactions at home with yeast, vinegar, baking soda and hydrogen peroxide.

Our paper on gender disparities in career outcomes for dementia researchers is out!
However, in this thread let me focus not on the results but on what Research at ARUK has done *this past year alone* to address the issues we found in this analysis.
amrcopenresearch.org/articles/4-18/…

Our new paper in JCR is a great example of why it’s so hard to treat neurological diseases. Getting drugs in the brain is just half the challenge- Ensuring they reach their target is a whole other hurdle! Rinie Bajracharya Juergen Goetz Queensland Brain Institute, UQ The Florey

Very excited to find out that our work The Florey to develop next generation immunotherapies for the treatment of AD has been funded by the Alzheimer's Association. Thank you Alzheimer's Association! Let’s #ENDALZ ! Laura Vella

Curious to hear what people think about open access publishing. In the last year I have spent almost $20k (AUD) 😬. It’s not very sustainable for a small lab! Should I not be choosing open access? 🤷🏻‍♀️

This is spot on 👇🏼